Table 5.
Po iPTH≥1.6 pmol/L N=197 | Po iPTH≥1 pmol/L N=237 | |||||
---|---|---|---|---|---|---|
<70% N=176 | >70% N=21 | P value | <70% N=194 | >70% N=43 | P value | |
Age (>45) | 57 (32.39%) | 10 (47.62%) | >0.999 | 62 (31.96%) | 16 (37.21%) | 0.591 |
Sex(male) | 63 (35.80%) | 5 (23.81%) | 0.337 | 66 (34.02%) | 9 (20.93%) | 0.106 |
Po hypomagnesemia | 29 (16.48%) | 5 (23.81%) | 0.372 | 35 (18.04%) | 12 (27.91%) | 0.145 |
Po hypocalcemia | 41 (23.30%) | 5 (23.81%) | >0.999 | 46 (23.71%) | 10 (23.26%) | >0.999 |
TTx | 175 (99.43%) | 20 (95.24%) | 0.202 | 193 (99.48%) | 42 (97.67%) | 0.331 |
bilateral CND | 113 (64.20%) | 11 (52.38%) | 0.341 | 129 (66.49%) | 24 (55.81%) | 0.365 |
SxH | 10 (5.68%) | 4 (19.05%) | 0.047 | 10 (5.15%) | 7 (16.28%) | 0.019 |
TTx total thyroidectomy, CT completion thyroidectomy, Po postoperative, CND central nodal dissection, iPTH intact parathyroid hormone, SxH symptomatic hypocalcemia